Magnolia Medical Technologies
Medical device company that develops, manufactures and markets innovative blood devices
Based in WA
🤖
AI Overview
With $370K in lobbying spend across 9 quarterly filings, Magnolia Medical Technologies is an active lobbying client. Their lobbying covers 5 issue areas. Active from 2020 to 2022.
$370K
Total Spend
3
Years Active
1
Firms Hired
3
Lobbyists Deployed
5
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2020 | $170K |
| 2021 | $200K |
| 2022 | $0 |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Medicare/Medicaid, MED, Veterans, Budget/Appropriations
- •Establishing new standard of care in sepsis testing accuracy
- •Advocating for the establishing a new standard of care in sepsis testing accuracy.
- •Advocating for the establishing a new standard of care in sepsis testing accuracy within the VA health system.
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
The 22,000% ROI
When lobbying spending yields outsized returns.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Seattle Children's Hospital Research and Foundation
$2.1M total spend
Seattle Children's Hospital Research and Foundation
$2.0M total spend
Providence St. Joseph Health
$4.3M total spend
Fred Hutchinson Cancer Center Former "fred Hutchison Cancer Research Center"
$1.3M total spend
Sound Physicians (FKA Sound Inpatient Physicians, INC.)
$1.1M total spend
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.